nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—CYP17A1—melanoma	0.233	0.529	CbGaD
Progesterone—CYP1B1—melanoma	0.162	0.366	CbGaD
Progesterone—ABCC1—Vemurafenib—melanoma	0.0693	0.192	CbGbCtD
Progesterone—ABCB1—melanoma	0.0464	0.105	CbGaD
Progesterone—ABCC1—Dactinomycin—melanoma	0.0461	0.128	CbGbCtD
Progesterone—CYP1B1—Docetaxel—melanoma	0.0335	0.093	CbGbCtD
Progesterone—CYP1A1—Dacarbazine—melanoma	0.0328	0.0911	CbGbCtD
Progesterone—CYP1A2—Carmustine—melanoma	0.0242	0.0672	CbGbCtD
Progesterone—ABCC1—Docetaxel—melanoma	0.0238	0.066	CbGbCtD
Progesterone—CYP1A2—Vemurafenib—melanoma	0.0191	0.0531	CbGbCtD
Progesterone—CYP3A4—Temozolomide—melanoma	0.0183	0.0508	CbGbCtD
Progesterone—CYP2D6—Vemurafenib—melanoma	0.0158	0.0438	CbGbCtD
Progesterone—CYP1A2—Dacarbazine—melanoma	0.0147	0.0407	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0118	0.0326	CbGbCtD
Progesterone—CYP3A7—Docetaxel—melanoma	0.0118	0.0326	CbGbCtD
Progesterone—ABCB1—Dactinomycin—melanoma	0.0111	0.0309	CbGbCtD
Progesterone—CYP3A4—Vemurafenib—melanoma	0.01	0.0278	CbGbCtD
Progesterone—CYP3A5—Docetaxel—melanoma	0.00882	0.0245	CbGbCtD
Progesterone—ABCB1—Docetaxel—melanoma	0.00574	0.0159	CbGbCtD
Progesterone—CYP3A4—Docetaxel—melanoma	0.00344	0.00955	CbGbCtD
Progesterone—SHBG—hindlimb—melanoma	0.00111	0.113	CbGeAlD
Progesterone—PGR—blood vessel—melanoma	0.000476	0.0486	CbGeAlD
Progesterone—CYP1B1—hair follicle—melanoma	0.000427	0.0436	CbGeAlD
Progesterone—CYP1A1—skin epidermis—melanoma	0.000423	0.0432	CbGeAlD
Progesterone—ABCC1—hair follicle—melanoma	0.000384	0.0392	CbGeAlD
Progesterone—SHBG—neck—melanoma	0.000378	0.0386	CbGeAlD
Progesterone—ESR1—blood vessel—melanoma	0.000372	0.038	CbGeAlD
Progesterone—Testosterone Propionate—CYP17A1—melanoma	0.000356	0.341	CrCbGaD
Progesterone—NR3C2—retina—melanoma	0.00027	0.0276	CbGeAlD
Progesterone—ESR1—neck—melanoma	0.000266	0.0272	CbGeAlD
Progesterone—SLC10A1—head—melanoma	0.000246	0.0251	CbGeAlD
Progesterone—SIGMAR1—eye—melanoma	0.000224	0.0229	CbGeAlD
Progesterone—OPRK1—head—melanoma	0.000217	0.0221	CbGeAlD
Progesterone—NR3C2—mammalian vulva—melanoma	0.000216	0.0221	CbGeAlD
Progesterone—CYP17A1—head—melanoma	0.000214	0.0219	CbGeAlD
Progesterone—CYP1B1—eye—melanoma	0.000213	0.0218	CbGeAlD
Progesterone—NR3C1—neck—melanoma	0.000197	0.0201	CbGeAlD
Progesterone—CYP1B1—skin of body—melanoma	0.000185	0.0189	CbGeAlD
Progesterone—SLC22A3—mammalian vulva—melanoma	0.000184	0.0188	CbGeAlD
Progesterone—SIGMAR1—mammalian vulva—melanoma	0.000178	0.0182	CbGeAlD
Progesterone—AR—skin of body—melanoma	0.000176	0.0179	CbGeAlD
Progesterone—Erythema—Dactinomycin—melanoma	0.000167	0.00157	CcSEcCtD
Progesterone—Pain in extremity—Docetaxel—melanoma	0.000167	0.00157	CcSEcCtD
Progesterone—Ill-defined disorder—Bleomycin—melanoma	0.000166	0.00156	CcSEcCtD
Progesterone—Anaemia—Bleomycin—melanoma	0.000166	0.00156	CcSEcCtD
Progesterone—Diarrhoea—Vemurafenib—melanoma	0.000165	0.00155	CcSEcCtD
Progesterone—Migraine—Docetaxel—melanoma	0.000164	0.00155	CcSEcCtD
Progesterone—Erythema multiforme—Temozolomide—melanoma	0.000164	0.00154	CcSEcCtD
Progesterone—Eye disorder—Temozolomide—melanoma	0.000162	0.00153	CcSEcCtD
Progesterone—Tinnitus—Temozolomide—melanoma	0.000162	0.00152	CcSEcCtD
Progesterone—Malaise—Bleomycin—melanoma	0.000162	0.00152	CcSEcCtD
Progesterone—Cardiac disorder—Temozolomide—melanoma	0.000161	0.00152	CcSEcCtD
Progesterone—AR—mammalian vulva—melanoma	0.00016	0.0164	CbGeAlD
Progesterone—Dizziness—Vemurafenib—melanoma	0.00016	0.0015	CcSEcCtD
Progesterone—Alopecia—Carmustine—melanoma	0.000159	0.00149	CcSEcCtD
Progesterone—Angiopathy—Temozolomide—melanoma	0.000158	0.00148	CcSEcCtD
Progesterone—Mental disorder—Carmustine—melanoma	0.000157	0.00148	CcSEcCtD
Progesterone—Immune system disorder—Temozolomide—melanoma	0.000157	0.00148	CcSEcCtD
Progesterone—Mediastinal disorder—Temozolomide—melanoma	0.000157	0.00147	CcSEcCtD
Progesterone—Erythema—Carmustine—melanoma	0.000156	0.00147	CcSEcCtD
Progesterone—Malnutrition—Carmustine—melanoma	0.000156	0.00147	CcSEcCtD
Progesterone—Cough—Bleomycin—melanoma	0.000156	0.00147	CcSEcCtD
Progesterone—Ill-defined disorder—Dactinomycin—melanoma	0.000155	0.00146	CcSEcCtD
Progesterone—NR3C2—head—melanoma	0.000155	0.0158	CbGeAlD
Progesterone—Anaemia—Dactinomycin—melanoma	0.000155	0.00145	CcSEcCtD
Progesterone—Liver function test abnormal—Docetaxel—melanoma	0.000154	0.00145	CcSEcCtD
Progesterone—Vomiting—Vemurafenib—melanoma	0.000154	0.00144	CcSEcCtD
Progesterone—Alopecia—Temozolomide—melanoma	0.000153	0.00144	CcSEcCtD
Progesterone—Chest pain—Bleomycin—melanoma	0.000153	0.00144	CcSEcCtD
Progesterone—Myalgia—Bleomycin—melanoma	0.000153	0.00144	CcSEcCtD
Progesterone—Rash—Vemurafenib—melanoma	0.000152	0.00143	CcSEcCtD
Progesterone—Mental disorder—Temozolomide—melanoma	0.000152	0.00143	CcSEcCtD
Progesterone—ABCC1—mammalian vulva—melanoma	0.000152	0.0155	CbGeAlD
Progesterone—Dermatitis—Vemurafenib—melanoma	0.000152	0.00143	CcSEcCtD
Progesterone—Back pain—Carmustine—melanoma	0.000151	0.00142	CcSEcCtD
Progesterone—Headache—Vemurafenib—melanoma	0.000151	0.00142	CcSEcCtD
Progesterone—Erythema—Temozolomide—melanoma	0.000151	0.00142	CcSEcCtD
Progesterone—Malnutrition—Temozolomide—melanoma	0.000151	0.00142	CcSEcCtD
Progesterone—Breast disorder—Docetaxel—melanoma	0.000151	0.00142	CcSEcCtD
Progesterone—Discomfort—Bleomycin—melanoma	0.000151	0.00142	CcSEcCtD
Progesterone—Malaise—Dactinomycin—melanoma	0.000151	0.00142	CcSEcCtD
Progesterone—Cramp muscle—Docetaxel—melanoma	0.00015	0.00141	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00015	0.00141	CcSEcCtD
Progesterone—CYP17A1—lymph node—melanoma	0.00015	0.0153	CbGeAlD
Progesterone—Nasopharyngitis—Docetaxel—melanoma	0.000149	0.0014	CcSEcCtD
Progesterone—Confusional state—Bleomycin—melanoma	0.000147	0.00139	CcSEcCtD
Progesterone—Vision blurred—Carmustine—melanoma	0.000147	0.00139	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Docetaxel—melanoma	0.000147	0.00138	CcSEcCtD
Progesterone—ABCB1—blood vessel—melanoma	0.000147	0.015	CbGeAlD
Progesterone—Tremor—Carmustine—melanoma	0.000147	0.00138	CcSEcCtD
Progesterone—Anaphylactic shock—Bleomycin—melanoma	0.000146	0.00138	CcSEcCtD
Progesterone—Oedema—Bleomycin—melanoma	0.000146	0.00138	CcSEcCtD
Progesterone—Back pain—Temozolomide—melanoma	0.000146	0.00138	CcSEcCtD
Progesterone—NR3C1—eye—melanoma	0.000146	0.0149	CbGeAlD
Progesterone—Infection—Bleomycin—melanoma	0.000145	0.00137	CcSEcCtD
Progesterone—Anaemia—Carmustine—melanoma	0.000145	0.00136	CcSEcCtD
Progesterone—Dysphagia—Docetaxel—melanoma	0.000144	0.00136	CcSEcCtD
Progesterone—PGR—head—melanoma	0.000144	0.0147	CbGeAlD
Progesterone—Nausea—Vemurafenib—melanoma	0.000143	0.00135	CcSEcCtD
Progesterone—Vision blurred—Temozolomide—melanoma	0.000142	0.00134	CcSEcCtD
Progesterone—Myalgia—Dactinomycin—melanoma	0.000142	0.00134	CcSEcCtD
Progesterone—Tremor—Temozolomide—melanoma	0.000142	0.00133	CcSEcCtD
Progesterone—Discomfort—Dactinomycin—melanoma	0.000141	0.00132	CcSEcCtD
Progesterone—Angina pectoris—Docetaxel—melanoma	0.000141	0.00132	CcSEcCtD
Progesterone—Ill-defined disorder—Temozolomide—melanoma	0.00014	0.00132	CcSEcCtD
Progesterone—Anaemia—Temozolomide—melanoma	0.00014	0.00131	CcSEcCtD
Progesterone—Anorexia—Bleomycin—melanoma	0.000139	0.00131	CcSEcCtD
Progesterone—Angioedema—Temozolomide—melanoma	0.000138	0.0013	CcSEcCtD
Progesterone—SLC22A1—head—melanoma	0.000138	0.0141	CbGeAlD
Progesterone—Hypotension—Bleomycin—melanoma	0.000137	0.00129	CcSEcCtD
Progesterone—Oedema—Dactinomycin—melanoma	0.000136	0.00128	CcSEcCtD
Progesterone—Malaise—Temozolomide—melanoma	0.000136	0.00128	CcSEcCtD
Progesterone—Vertigo—Temozolomide—melanoma	0.000136	0.00128	CcSEcCtD
Progesterone—Convulsion—Carmustine—melanoma	0.000136	0.00127	CcSEcCtD
Progesterone—Infection—Dactinomycin—melanoma	0.000136	0.00127	CcSEcCtD
Progesterone—Hypertension—Carmustine—melanoma	0.000135	0.00127	CcSEcCtD
Progesterone—Palpitations—Temozolomide—melanoma	0.000134	0.00126	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000133	0.00125	CcSEcCtD
Progesterone—Chest pain—Carmustine—melanoma	0.000133	0.00125	CcSEcCtD
Progesterone—Myalgia—Carmustine—melanoma	0.000133	0.00125	CcSEcCtD
Progesterone—Anxiety—Carmustine—melanoma	0.000133	0.00125	CcSEcCtD
Progesterone—Cough—Temozolomide—melanoma	0.000132	0.00124	CcSEcCtD
Progesterone—SLC22A3—head—melanoma	0.000132	0.0134	CbGeAlD
Progesterone—Paraesthesia—Bleomycin—melanoma	0.000131	0.00124	CcSEcCtD
Progesterone—Weight increased—Docetaxel—melanoma	0.000131	0.00124	CcSEcCtD
Progesterone—CYP1A1—skin of body—melanoma	0.000131	0.0134	CbGeAlD
Progesterone—Convulsion—Temozolomide—melanoma	0.000131	0.00123	CcSEcCtD
Progesterone—Weight decreased—Docetaxel—melanoma	0.000131	0.00123	CcSEcCtD
Progesterone—Hypertension—Temozolomide—melanoma	0.000131	0.00123	CcSEcCtD
Progesterone—Dyspnoea—Bleomycin—melanoma	0.00013	0.00123	CcSEcCtD
Progesterone—Anorexia—Dactinomycin—melanoma	0.00013	0.00122	CcSEcCtD
Progesterone—Pneumonia—Docetaxel—melanoma	0.000129	0.00122	CcSEcCtD
Progesterone—Confusional state—Carmustine—melanoma	0.000129	0.00121	CcSEcCtD
Progesterone—Arthralgia—Temozolomide—melanoma	0.000129	0.00121	CcSEcCtD
Progesterone—Myalgia—Temozolomide—melanoma	0.000129	0.00121	CcSEcCtD
Progesterone—Infestation NOS—Docetaxel—melanoma	0.000129	0.00121	CcSEcCtD
Progesterone—Infestation—Docetaxel—melanoma	0.000129	0.00121	CcSEcCtD
Progesterone—Anxiety—Temozolomide—melanoma	0.000128	0.00121	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000128	0.0012	CcSEcCtD
Progesterone—Oedema—Carmustine—melanoma	0.000128	0.0012	CcSEcCtD
Progesterone—NR3C1—skin of body—melanoma	0.000127	0.013	CbGeAlD
Progesterone—Discomfort—Temozolomide—melanoma	0.000127	0.0012	CcSEcCtD
Progesterone—Decreased appetite—Bleomycin—melanoma	0.000127	0.0012	CcSEcCtD
Progesterone—Infection—Carmustine—melanoma	0.000127	0.00119	CcSEcCtD
Progesterone—Neuropathy peripheral—Docetaxel—melanoma	0.000126	0.00119	CcSEcCtD
Progesterone—Dry mouth—Temozolomide—melanoma	0.000126	0.00118	CcSEcCtD
Progesterone—Jaundice—Docetaxel—melanoma	0.000125	0.00118	CcSEcCtD
Progesterone—Pain—Bleomycin—melanoma	0.000125	0.00118	CcSEcCtD
Progesterone—Conjunctivitis—Docetaxel—melanoma	0.000125	0.00118	CcSEcCtD
Progesterone—Tachycardia—Carmustine—melanoma	0.000125	0.00117	CcSEcCtD
Progesterone—Confusional state—Temozolomide—melanoma	0.000124	0.00117	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000124	0.00117	CcSEcCtD
Progesterone—Oedema—Temozolomide—melanoma	0.000123	0.00116	CcSEcCtD
Progesterone—Anaphylactic shock—Temozolomide—melanoma	0.000123	0.00116	CcSEcCtD
Progesterone—Infection—Temozolomide—melanoma	0.000123	0.00115	CcSEcCtD
Progesterone—Anorexia—Carmustine—melanoma	0.000122	0.00114	CcSEcCtD
Progesterone—Hepatobiliary disease—Docetaxel—melanoma	0.000122	0.00114	CcSEcCtD
Progesterone—Nervous system disorder—Temozolomide—melanoma	0.000121	0.00114	CcSEcCtD
Progesterone—CYP1B1—head—melanoma	0.000121	0.0124	CbGeAlD
Progesterone—Feeling abnormal—Bleomycin—melanoma	0.000121	0.00113	CcSEcCtD
Progesterone—Skin disorder—Temozolomide—melanoma	0.00012	0.00113	CcSEcCtD
Progesterone—CYP1A1—mammalian vulva—melanoma	0.00012	0.0122	CbGeAlD
Progesterone—Hypotension—Carmustine—melanoma	0.000119	0.00112	CcSEcCtD
Progesterone—Hyperhidrosis—Temozolomide—melanoma	0.000119	0.00112	CcSEcCtD
Progesterone—Decreased appetite—Dactinomycin—melanoma	0.000119	0.00112	CcSEcCtD
Progesterone—Fatigue—Dactinomycin—melanoma	0.000118	0.00111	CcSEcCtD
Progesterone—Anorexia—Temozolomide—melanoma	0.000118	0.00111	CcSEcCtD
Progesterone—Pain—Dactinomycin—melanoma	0.000117	0.0011	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Carmustine—melanoma	0.000116	0.00109	CcSEcCtD
Progesterone—Urticaria—Bleomycin—melanoma	0.000116	0.00109	CcSEcCtD
Progesterone—Haemoglobin—Docetaxel—melanoma	0.000116	0.00109	CcSEcCtD
Progesterone—NR3C1—mammalian vulva—melanoma	0.000116	0.0118	CbGeAlD
Progesterone—Rhinitis—Docetaxel—melanoma	0.000116	0.00109	CcSEcCtD
Progesterone—Body temperature increased—Bleomycin—melanoma	0.000116	0.00109	CcSEcCtD
Progesterone—Haemorrhage—Docetaxel—melanoma	0.000116	0.00109	CcSEcCtD
Progesterone—Hepatitis—Docetaxel—melanoma	0.000116	0.00109	CcSEcCtD
Progesterone—Insomnia—Carmustine—melanoma	0.000115	0.00109	CcSEcCtD
Progesterone—Paraesthesia—Carmustine—melanoma	0.000115	0.00108	CcSEcCtD
Progesterone—Pharyngitis—Docetaxel—melanoma	0.000115	0.00108	CcSEcCtD
Progesterone—AR—head—melanoma	0.000115	0.0117	CbGeAlD
Progesterone—Urinary tract disorder—Docetaxel—melanoma	0.000114	0.00107	CcSEcCtD
Progesterone—Dyspnoea—Carmustine—melanoma	0.000114	0.00107	CcSEcCtD
Progesterone—Oedema peripheral—Docetaxel—melanoma	0.000114	0.00107	CcSEcCtD
Progesterone—Somnolence—Carmustine—melanoma	0.000114	0.00107	CcSEcCtD
Progesterone—Connective tissue disorder—Docetaxel—melanoma	0.000114	0.00107	CcSEcCtD
Progesterone—Urethral disorder—Docetaxel—melanoma	0.000113	0.00106	CcSEcCtD
Progesterone—ESR1—head—melanoma	0.000112	0.0115	CbGeAlD
Progesterone—Feeling abnormal—Dactinomycin—melanoma	0.000112	0.00106	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000112	0.00106	CcSEcCtD
Progesterone—Insomnia—Temozolomide—melanoma	0.000112	0.00105	CcSEcCtD
Progesterone—Gastrointestinal pain—Dactinomycin—melanoma	0.000112	0.00105	CcSEcCtD
Progesterone—Visual impairment—Docetaxel—melanoma	0.000111	0.00105	CcSEcCtD
Progesterone—Decreased appetite—Carmustine—melanoma	0.000111	0.00104	CcSEcCtD
Progesterone—Paraesthesia—Temozolomide—melanoma	0.000111	0.00104	CcSEcCtD
Progesterone—Gastrointestinal disorder—Carmustine—melanoma	0.00011	0.00104	CcSEcCtD
Progesterone—Dyspnoea—Temozolomide—melanoma	0.00011	0.00103	CcSEcCtD
Progesterone—Somnolence—Temozolomide—melanoma	0.00011	0.00103	CcSEcCtD
Progesterone—Erythema multiforme—Docetaxel—melanoma	0.000109	0.00103	CcSEcCtD
Progesterone—Pain—Carmustine—melanoma	0.000109	0.00103	CcSEcCtD
Progesterone—Constipation—Carmustine—melanoma	0.000109	0.00103	CcSEcCtD
Progesterone—Dyspepsia—Temozolomide—melanoma	0.000109	0.00102	CcSEcCtD
Progesterone—NR3C2—lymph node—melanoma	0.000108	0.0111	CbGeAlD
Progesterone—Eye disorder—Docetaxel—melanoma	0.000108	0.00102	CcSEcCtD
Progesterone—Abdominal pain—Dactinomycin—melanoma	0.000108	0.00101	CcSEcCtD
Progesterone—Body temperature increased—Dactinomycin—melanoma	0.000108	0.00101	CcSEcCtD
Progesterone—Hypersensitivity—Bleomycin—melanoma	0.000108	0.00101	CcSEcCtD
Progesterone—Decreased appetite—Temozolomide—melanoma	0.000107	0.00101	CcSEcCtD
Progesterone—Cardiac disorder—Docetaxel—melanoma	0.000107	0.00101	CcSEcCtD
Progesterone—Testosterone—CYP1B1—melanoma	0.000107	0.103	CrCbGaD
Progesterone—Gastrointestinal disorder—Temozolomide—melanoma	0.000107	0.001	CcSEcCtD
Progesterone—Fatigue—Temozolomide—melanoma	0.000106	0.001	CcSEcCtD
Progesterone—Constipation—Temozolomide—melanoma	0.000106	0.000992	CcSEcCtD
Progesterone—Pain—Temozolomide—melanoma	0.000106	0.000992	CcSEcCtD
Progesterone—Feeling abnormal—Carmustine—melanoma	0.000105	0.00099	CcSEcCtD
Progesterone—Asthenia—Bleomycin—melanoma	0.000105	0.000987	CcSEcCtD
Progesterone—Angiopathy—Docetaxel—melanoma	0.000105	0.000986	CcSEcCtD
Progesterone—Gastrointestinal pain—Carmustine—melanoma	0.000104	0.000982	CcSEcCtD
Progesterone—Immune system disorder—Docetaxel—melanoma	0.000104	0.000981	CcSEcCtD
Progesterone—Mediastinal disorder—Docetaxel—melanoma	0.000104	0.000979	CcSEcCtD
Progesterone—Pruritus—Bleomycin—melanoma	0.000103	0.000973	CcSEcCtD
Progesterone—Alopecia—Docetaxel—melanoma	0.000102	0.00096	CcSEcCtD
Progesterone—Feeling abnormal—Temozolomide—melanoma	0.000102	0.000956	CcSEcCtD
Progesterone—Mental disorder—Docetaxel—melanoma	0.000101	0.000952	CcSEcCtD
Progesterone—Abdominal pain—Carmustine—melanoma	0.000101	0.000949	CcSEcCtD
Progesterone—Body temperature increased—Carmustine—melanoma	0.000101	0.000949	CcSEcCtD
Progesterone—Gastrointestinal pain—Temozolomide—melanoma	0.000101	0.000949	CcSEcCtD
Progesterone—PGR—lymph node—melanoma	0.000101	0.0103	CbGeAlD
Progesterone—Erythema—Docetaxel—melanoma	0.000101	0.000946	CcSEcCtD
Progesterone—Malnutrition—Docetaxel—melanoma	0.000101	0.000946	CcSEcCtD
Progesterone—Hypersensitivity—Dactinomycin—melanoma	0.000101	0.000945	CcSEcCtD
Progesterone—Drospirenone—PTGS2—melanoma	9.91e-05	0.0951	CrCbGaD
Progesterone—Urticaria—Temozolomide—melanoma	9.8e-05	0.000922	CcSEcCtD
Progesterone—Asthenia—Dactinomycin—melanoma	9.79e-05	0.000921	CcSEcCtD
Progesterone—Abdominal pain—Temozolomide—melanoma	9.75e-05	0.000917	CcSEcCtD
Progesterone—Body temperature increased—Temozolomide—melanoma	9.75e-05	0.000917	CcSEcCtD
Progesterone—Back pain—Docetaxel—melanoma	9.73e-05	0.000915	CcSEcCtD
Progesterone—Muscle spasms—Docetaxel—melanoma	9.67e-05	0.000909	CcSEcCtD
Progesterone—Megestrol acetate—ABCB1—melanoma	9.65e-05	0.0926	CrCbGaD
Progesterone—Hypersensitivity—Carmustine—melanoma	9.41e-05	0.000885	CcSEcCtD
Progesterone—Diarrhoea—Dactinomycin—melanoma	9.33e-05	0.000878	CcSEcCtD
Progesterone—Vomiting—Bleomycin—melanoma	9.3e-05	0.000875	CcSEcCtD
Progesterone—Anaemia—Docetaxel—melanoma	9.29e-05	0.000874	CcSEcCtD
Progesterone—Rash—Bleomycin—melanoma	9.22e-05	0.000867	CcSEcCtD
Progesterone—SLC22A3—lymph node—melanoma	9.22e-05	0.00941	CbGeAlD
Progesterone—Dermatitis—Bleomycin—melanoma	9.21e-05	0.000867	CcSEcCtD
Progesterone—Asthenia—Carmustine—melanoma	9.16e-05	0.000862	CcSEcCtD
Progesterone—Hypersensitivity—Temozolomide—melanoma	9.09e-05	0.000855	CcSEcCtD
Progesterone—Syncope—Docetaxel—melanoma	9.02e-05	0.000848	CcSEcCtD
Progesterone—SIGMAR1—lymph node—melanoma	8.91e-05	0.0091	CbGeAlD
Progesterone—Palpitations—Docetaxel—melanoma	8.89e-05	0.000836	CcSEcCtD
Progesterone—Asthenia—Temozolomide—melanoma	8.85e-05	0.000833	CcSEcCtD
Progesterone—Loss of consciousness—Docetaxel—melanoma	8.84e-05	0.000831	CcSEcCtD
Progesterone—Cough—Docetaxel—melanoma	8.77e-05	0.000825	CcSEcCtD
Progesterone—Diarrhoea—Carmustine—melanoma	8.74e-05	0.000822	CcSEcCtD
Progesterone—Pruritus—Temozolomide—melanoma	8.73e-05	0.000821	CcSEcCtD
Progesterone—Convulsion—Docetaxel—melanoma	8.71e-05	0.000819	CcSEcCtD
Progesterone—Nausea—Bleomycin—melanoma	8.69e-05	0.000817	CcSEcCtD
Progesterone—Hypertension—Docetaxel—melanoma	8.68e-05	0.000816	CcSEcCtD
Progesterone—Vomiting—Dactinomycin—melanoma	8.67e-05	0.000816	CcSEcCtD
Progesterone—Rash—Dactinomycin—melanoma	8.6e-05	0.000809	CcSEcCtD
Progesterone—Myalgia—Docetaxel—melanoma	8.56e-05	0.000805	CcSEcCtD
Progesterone—Chest pain—Docetaxel—melanoma	8.56e-05	0.000805	CcSEcCtD
Progesterone—Arthralgia—Docetaxel—melanoma	8.56e-05	0.000805	CcSEcCtD
Progesterone—CYP1A1—head—melanoma	8.55e-05	0.00873	CbGeAlD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	8.5e-05	0.0008	CcSEcCtD
Progesterone—CYP1B1—lymph node—melanoma	8.47e-05	0.00865	CbGeAlD
Progesterone—Dizziness—Carmustine—melanoma	8.44e-05	0.000794	CcSEcCtD
Progesterone—Diarrhoea—Temozolomide—melanoma	8.44e-05	0.000794	CcSEcCtD
Progesterone—Dry mouth—Docetaxel—melanoma	8.37e-05	0.000787	CcSEcCtD
Progesterone—NR3C1—head—melanoma	8.3e-05	0.00847	CbGeAlD
Progesterone—Confusional state—Docetaxel—melanoma	8.27e-05	0.000778	CcSEcCtD
Progesterone—Anaphylactic shock—Docetaxel—melanoma	8.21e-05	0.000772	CcSEcCtD
Progesterone—Oedema—Docetaxel—melanoma	8.21e-05	0.000772	CcSEcCtD
Progesterone—Dizziness—Temozolomide—melanoma	8.16e-05	0.000767	CcSEcCtD
Progesterone—Infection—Docetaxel—melanoma	8.15e-05	0.000767	CcSEcCtD
Progesterone—Vomiting—Carmustine—melanoma	8.12e-05	0.000764	CcSEcCtD
Progesterone—Nausea—Dactinomycin—melanoma	8.1e-05	0.000762	CcSEcCtD
Progesterone—Shock—Docetaxel—melanoma	8.07e-05	0.000759	CcSEcCtD
Progesterone—Rash—Carmustine—melanoma	8.05e-05	0.000757	CcSEcCtD
Progesterone—Nervous system disorder—Docetaxel—melanoma	8.05e-05	0.000757	CcSEcCtD
Progesterone—Dermatitis—Carmustine—melanoma	8.04e-05	0.000757	CcSEcCtD
Progesterone—AR—lymph node—melanoma	8.02e-05	0.00819	CbGeAlD
Progesterone—Tachycardia—Docetaxel—melanoma	8.01e-05	0.000753	CcSEcCtD
Progesterone—Headache—Carmustine—melanoma	8e-05	0.000752	CcSEcCtD
Progesterone—Skin disorder—Docetaxel—melanoma	7.97e-05	0.00075	CcSEcCtD
Progesterone—ESR1—lymph node—melanoma	7.88e-05	0.00804	CbGeAlD
Progesterone—Vomiting—Temozolomide—melanoma	7.85e-05	0.000738	CcSEcCtD
Progesterone—Anorexia—Docetaxel—melanoma	7.82e-05	0.000736	CcSEcCtD
Progesterone—Rash—Temozolomide—melanoma	7.78e-05	0.000732	CcSEcCtD
Progesterone—Dermatitis—Temozolomide—melanoma	7.77e-05	0.000731	CcSEcCtD
Progesterone—ABCB1—retina—melanoma	7.76e-05	0.00792	CbGeAlD
Progesterone—Headache—Temozolomide—melanoma	7.73e-05	0.000727	CcSEcCtD
Progesterone—Hypotension—Docetaxel—melanoma	7.67e-05	0.000721	CcSEcCtD
Progesterone—ABCC1—lymph node—melanoma	7.62e-05	0.00778	CbGeAlD
Progesterone—Nausea—Carmustine—melanoma	7.58e-05	0.000713	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Docetaxel—melanoma	7.48e-05	0.000703	CcSEcCtD
Progesterone—Insomnia—Docetaxel—melanoma	7.42e-05	0.000698	CcSEcCtD
Progesterone—Paraesthesia—Docetaxel—melanoma	7.37e-05	0.000693	CcSEcCtD
Progesterone—Nausea—Temozolomide—melanoma	7.33e-05	0.000689	CcSEcCtD
Progesterone—Dyspnoea—Docetaxel—melanoma	7.32e-05	0.000688	CcSEcCtD
Progesterone—Somnolence—Docetaxel—melanoma	7.3e-05	0.000686	CcSEcCtD
Progesterone—Dyspepsia—Docetaxel—melanoma	7.22e-05	0.000679	CcSEcCtD
Progesterone—Decreased appetite—Docetaxel—melanoma	7.13e-05	0.000671	CcSEcCtD
Progesterone—Gastrointestinal disorder—Docetaxel—melanoma	7.08e-05	0.000666	CcSEcCtD
Progesterone—Fatigue—Docetaxel—melanoma	7.07e-05	0.000665	CcSEcCtD
Progesterone—Constipation—Docetaxel—melanoma	7.02e-05	0.00066	CcSEcCtD
Progesterone—Pain—Docetaxel—melanoma	7.02e-05	0.00066	CcSEcCtD
Progesterone—Feeling abnormal—Docetaxel—melanoma	6.76e-05	0.000636	CcSEcCtD
Progesterone—Gastrointestinal pain—Docetaxel—melanoma	6.71e-05	0.000631	CcSEcCtD
Progesterone—Abdominal pain—Docetaxel—melanoma	6.49e-05	0.00061	CcSEcCtD
Progesterone—Body temperature increased—Docetaxel—melanoma	6.49e-05	0.00061	CcSEcCtD
Progesterone—ABCB1—mammalian vulva—melanoma	6.21e-05	0.00634	CbGeAlD
Progesterone—CYP2D6—head—melanoma	6.18e-05	0.00631	CbGeAlD
Progesterone—Hypersensitivity—Docetaxel—melanoma	6.05e-05	0.000569	CcSEcCtD
Progesterone—Spironolactone—ABCB1—melanoma	6e-05	0.0576	CrCbGaD
Progesterone—CYP1A1—lymph node—melanoma	5.99e-05	0.00612	CbGeAlD
Progesterone—Asthenia—Docetaxel—melanoma	5.89e-05	0.000554	CcSEcCtD
Progesterone—Norethindrone—ALB—melanoma	5.84e-05	0.056	CrCbGaD
Progesterone—NR3C1—lymph node—melanoma	5.81e-05	0.00593	CbGeAlD
Progesterone—Pruritus—Docetaxel—melanoma	5.81e-05	0.000546	CcSEcCtD
Progesterone—Diarrhoea—Docetaxel—melanoma	5.61e-05	0.000528	CcSEcCtD
Progesterone—Norethindrone—ABCB1—melanoma	5.57e-05	0.0535	CrCbGaD
Progesterone—Methyltestosterone—ALB—melanoma	5.55e-05	0.0532	CrCbGaD
Progesterone—Dizziness—Docetaxel—melanoma	5.43e-05	0.00051	CcSEcCtD
Progesterone—Vomiting—Docetaxel—melanoma	5.22e-05	0.000491	CcSEcCtD
Progesterone—Prednisolone—ABCB1—melanoma	5.21e-05	0.05	CrCbGaD
Progesterone—Rash—Docetaxel—melanoma	5.17e-05	0.000487	CcSEcCtD
Progesterone—Dermatitis—Docetaxel—melanoma	5.17e-05	0.000486	CcSEcCtD
Progesterone—Headache—Docetaxel—melanoma	5.14e-05	0.000483	CcSEcCtD
Progesterone—Nausea—Docetaxel—melanoma	4.87e-05	0.000458	CcSEcCtD
Progesterone—ABCB1—head—melanoma	4.44e-05	0.00454	CbGeAlD
Progesterone—Hydrocortisone—ABCB1—melanoma	3.99e-05	0.0382	CrCbGaD
Progesterone—Testosterone—ALB—melanoma	3.22e-05	0.0309	CrCbGaD
Progesterone—ABCB1—lymph node—melanoma	3.11e-05	0.00318	CbGeAlD
Progesterone—Testosterone—ABCB1—melanoma	3.07e-05	0.0294	CrCbGaD
Progesterone—CYP2C9—Metabolism—CYP1B1—melanoma	2.77e-06	3.39e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGF—melanoma	2.75e-06	3.37e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CB—melanoma	2.74e-06	3.36e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.73e-06	3.35e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL8—melanoma	2.73e-06	3.35e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—melanoma	2.71e-06	3.33e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—melanoma	2.71e-06	3.33e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK3—melanoma	2.68e-06	3.28e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.68e-06	3.28e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1B—melanoma	2.67e-06	3.27e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GNA11—melanoma	2.65e-06	3.25e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—melanoma	2.64e-06	3.23e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CD—melanoma	2.64e-06	3.23e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—melanoma	2.61e-06	3.2e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—melanoma	2.61e-06	3.2e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—melanoma	2.61e-06	3.2e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL2—melanoma	2.61e-06	3.2e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—melanoma	2.61e-06	3.2e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—melanoma	2.6e-06	3.19e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ALB—melanoma	2.6e-06	3.19e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CD—melanoma	2.6e-06	3.18e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL6—melanoma	2.6e-06	3.18e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—FASN—melanoma	2.6e-06	3.18e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PRKCA—melanoma	2.58e-06	3.16e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—VCAN—melanoma	2.57e-06	3.15e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ALB—melanoma	2.56e-06	3.14e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ERCC2—melanoma	2.56e-06	3.13e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC5A5—melanoma	2.55e-06	3.13e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MAPK1—melanoma	2.55e-06	3.12e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—melanoma	2.55e-06	3.12e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IGF1—melanoma	2.54e-06	3.12e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—melanoma	2.54e-06	3.12e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—melanoma	2.52e-06	3.09e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ABCB1—melanoma	2.5e-06	3.06e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK3—melanoma	2.5e-06	3.06e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CB—melanoma	2.47e-06	3.03e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MMP9—melanoma	2.47e-06	3.03e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GNAQ—melanoma	2.47e-06	3.02e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CD44—melanoma	2.47e-06	3.02e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CB—melanoma	2.47e-06	3.02e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1A—melanoma	2.46e-06	3.02e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAP2K1—melanoma	2.46e-06	3.01e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—melanoma	2.46e-06	3.01e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—melanoma	2.45e-06	3e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—melanoma	2.45e-06	3e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—melanoma	2.44e-06	3e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NFKB1—melanoma	2.44e-06	3e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CD—melanoma	2.44e-06	2.99e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.44e-06	2.99e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—melanoma	2.43e-06	2.98e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MAPK3—melanoma	2.42e-06	2.96e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.41e-06	2.96e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—melanoma	2.41e-06	2.95e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—melanoma	2.4e-06	2.94e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—melanoma	2.4e-06	2.94e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.39e-06	2.93e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MAPK3—melanoma	2.38e-06	2.92e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK1—melanoma	2.38e-06	2.91e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—melanoma	2.37e-06	2.91e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—melanoma	2.37e-06	2.9e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP1B1—melanoma	2.36e-06	2.9e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—melanoma	2.35e-06	2.88e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FGF2—melanoma	2.34e-06	2.87e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—melanoma	2.34e-06	2.87e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—melanoma	2.33e-06	2.86e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—melanoma	2.32e-06	2.84e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.31e-06	2.83e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PRKCA—melanoma	2.3e-06	2.82e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—melanoma	2.3e-06	2.82e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ABCB1—melanoma	2.3e-06	2.82e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—melanoma	2.3e-06	2.82e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ERCC2—melanoma	2.28e-06	2.8e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ABCB1—melanoma	2.28e-06	2.79e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—melanoma	2.28e-06	2.79e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—melanoma	2.26e-06	2.78e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARG—melanoma	2.25e-06	2.76e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PRKCA—melanoma	2.24e-06	2.75e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—melanoma	2.24e-06	2.75e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—melanoma	2.24e-06	2.75e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ERCC2—melanoma	2.23e-06	2.73e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—melanoma	2.22e-06	2.72e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—melanoma	2.21e-06	2.71e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—melanoma	2.2e-06	2.7e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—melanoma	2.2e-06	2.69e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—melanoma	2.19e-06	2.69e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—melanoma	2.19e-06	2.68e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP17A1—melanoma	2.17e-06	2.66e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—ERBB2—melanoma	2.16e-06	2.65e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—melanoma	2.14e-06	2.62e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—melanoma	2.13e-06	2.62e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—melanoma	2.13e-06	2.61e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—melanoma	2.13e-06	2.61e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARG—melanoma	2.12e-06	2.6e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—melanoma	2.12e-06	2.6e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.12e-06	2.6e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PRKCA—melanoma	2.12e-06	2.59e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ERCC2—melanoma	2.1e-06	2.57e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK3—melanoma	2.1e-06	2.57e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PRKCA—melanoma	2.1e-06	2.57e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.09e-06	2.56e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ERCC2—melanoma	2.08e-06	2.55e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—melanoma	2.06e-06	2.53e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—melanoma	2.05e-06	2.51e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GNA11—melanoma	2.05e-06	2.51e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—melanoma	2.05e-06	2.51e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—melanoma	2.05e-06	2.51e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—melanoma	2.04e-06	2.5e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ALB—melanoma	2.02e-06	2.48e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—melanoma	2.02e-06	2.47e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—FASN—melanoma	2e-06	2.46e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1B—melanoma	2e-06	2.45e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK1—melanoma	2e-06	2.45e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—melanoma	2e-06	2.45e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—melanoma	1.99e-06	2.44e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC5A5—melanoma	1.97e-06	2.42e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—melanoma	1.96e-06	2.4e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—melanoma	1.96e-06	2.4e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—melanoma	1.96e-06	2.4e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—melanoma	1.96e-06	2.4e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—melanoma	1.96e-06	2.4e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARG—melanoma	1.95e-06	2.39e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ABCB1—melanoma	1.95e-06	2.39e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—melanoma	1.94e-06	2.37e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ALB—melanoma	1.91e-06	2.34e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—melanoma	1.91e-06	2.34e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—melanoma	1.91e-06	2.34e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CD44—melanoma	1.9e-06	2.33e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GNAQ—melanoma	1.9e-06	2.33e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.89e-06	2.32e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—melanoma	1.89e-06	2.31e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—melanoma	1.89e-06	2.31e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—melanoma	1.88e-06	2.3e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MMP9—melanoma	1.85e-06	2.27e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1A—melanoma	1.84e-06	2.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—melanoma	1.84e-06	2.26e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NFKB1—melanoma	1.83e-06	2.24e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—melanoma	1.83e-06	2.24e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP1B1—melanoma	1.82e-06	2.24e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—melanoma	1.81e-06	2.21e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—melanoma	1.8e-06	2.21e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PRKCA—melanoma	1.79e-06	2.2e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—melanoma	1.79e-06	2.19e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ERCC2—melanoma	1.78e-06	2.18e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—melanoma	1.77e-06	2.18e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—melanoma	1.77e-06	2.17e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—melanoma	1.76e-06	2.16e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ALB—melanoma	1.75e-06	2.15e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARG—melanoma	1.74e-06	2.13e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—melanoma	1.73e-06	2.12e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—melanoma	1.73e-06	2.12e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.72e-06	2.11e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARG—melanoma	1.7e-06	2.08e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—melanoma	1.69e-06	2.07e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—melanoma	1.68e-06	2.06e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—melanoma	1.68e-06	2.05e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—melanoma	1.67e-06	2.05e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—melanoma	1.67e-06	2.05e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—melanoma	1.66e-06	2.04e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—melanoma	1.66e-06	2.03e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—melanoma	1.65e-06	2.02e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—melanoma	1.64e-06	2.01e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—melanoma	1.64e-06	2.01e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—melanoma	1.63e-06	2e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—melanoma	1.61e-06	1.97e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—melanoma	1.6e-06	1.96e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARG—melanoma	1.6e-06	1.96e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARG—melanoma	1.59e-06	1.94e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—melanoma	1.58e-06	1.94e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK3—melanoma	1.57e-06	1.93e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ALB—melanoma	1.56e-06	1.92e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—melanoma	1.55e-06	1.9e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—melanoma	1.55e-06	1.89e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—melanoma	1.54e-06	1.89e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—melanoma	1.53e-06	1.88e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—melanoma	1.53e-06	1.88e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—melanoma	1.53e-06	1.87e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ALB—melanoma	1.53e-06	1.87e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—melanoma	1.51e-06	1.85e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—melanoma	1.5e-06	1.84e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCB1—melanoma	1.5e-06	1.84e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK1—melanoma	1.5e-06	1.83e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—melanoma	1.5e-06	1.83e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.47e-06	1.8e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—melanoma	1.46e-06	1.79e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—melanoma	1.46e-06	1.79e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—melanoma	1.44e-06	1.77e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ALB—melanoma	1.44e-06	1.76e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ALB—melanoma	1.43e-06	1.75e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—melanoma	1.41e-06	1.73e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—melanoma	1.41e-06	1.73e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—melanoma	1.41e-06	1.73e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—melanoma	1.4e-06	1.72e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—melanoma	1.4e-06	1.72e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PRKCA—melanoma	1.38e-06	1.7e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—melanoma	1.38e-06	1.69e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—melanoma	1.38e-06	1.69e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ERCC2—melanoma	1.37e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—melanoma	1.37e-06	1.68e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—melanoma	1.36e-06	1.67e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARG—melanoma	1.35e-06	1.66e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—melanoma	1.35e-06	1.65e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—melanoma	1.34e-06	1.64e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—melanoma	1.33e-06	1.64e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—melanoma	1.3e-06	1.59e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—melanoma	1.27e-06	1.56e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—melanoma	1.26e-06	1.54e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—melanoma	1.26e-06	1.54e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—melanoma	1.26e-06	1.54e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—melanoma	1.25e-06	1.53e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—melanoma	1.23e-06	1.51e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—melanoma	1.23e-06	1.51e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—melanoma	1.23e-06	1.51e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ALB—melanoma	1.22e-06	1.49e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—melanoma	1.2e-06	1.47e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—melanoma	1.19e-06	1.46e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—melanoma	1.16e-06	1.43e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—melanoma	1.15e-06	1.41e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—melanoma	1.14e-06	1.4e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—melanoma	1.13e-06	1.38e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—melanoma	1.1e-06	1.34e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—melanoma	1.09e-06	1.33e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—melanoma	1.09e-06	1.33e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—melanoma	1.08e-06	1.33e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—melanoma	1.08e-06	1.32e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—melanoma	1.07e-06	1.31e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—melanoma	1.06e-06	1.3e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARG—melanoma	1.05e-06	1.28e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—melanoma	1.03e-06	1.26e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—melanoma	9.52e-07	1.17e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—melanoma	9.43e-07	1.16e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALB—melanoma	9.4e-07	1.15e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—melanoma	9.29e-07	1.14e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—melanoma	8.89e-07	1.09e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—melanoma	8.41e-07	1.03e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—melanoma	8.4e-07	1.03e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—melanoma	8.3e-07	1.02e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—melanoma	8.22e-07	1.01e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—melanoma	8.21e-07	1.01e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—melanoma	7.74e-07	9.49e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—melanoma	7.7e-07	9.44e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—melanoma	7.67e-07	9.41e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—melanoma	7.17e-07	8.79e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—melanoma	6.87e-07	8.43e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—melanoma	6.71e-07	8.23e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—melanoma	6.56e-07	8.04e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—melanoma	6.32e-07	7.75e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—melanoma	6.27e-07	7.68e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—melanoma	5.36e-07	6.57e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—melanoma	5.06e-07	6.2e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—melanoma	4.13e-07	5.07e-06	CbGpPWpGaD
